Frank Szulzewsky1,2, Nina Schwendinger1, Dilansu Güneykaya1, Patrick J Cimino2,3, Dolores Hambardzumyan4, Michael Synowitz5, Eric C Holland2, Helmut Kettenmann1. 1. Cellular Neurosciences, Max Delbrueck Center for Molecular Medicine in the Helmholtz Association and Berlin Institute of Health, Berlin, Germany. 2. Department of Human Biology, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA. 3. Department of Pathology, University of Washington School of Medicine, Seattle, Washington, USA. 4. Department of Pediatrics, Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Emory University School of Medicine, Atlanta, Georgia, USA. 5. Department of Neurosurgery, University Medical Center Schleswig-Holstein, Kiel, Germany.
Abstract
Background: Microglia and periphery-derived monocytes infiltrate human and mouse glioblastoma and their density is positively correlated with malignancy. Using microarray and RNA sequencing, we have previously shown that glioblastoma-associated microglia/monocytes (GAMs) express osteopontin/SPP1. Methods: We used quantitative reverse transcriptase PCR, immunofluorescence stainings, western blot, and flow cytometry to identify the various sources of osteopontin (OPN) expression in human and mouse glioblastoma. We implanted wild type GL261 glioblastoma cells, which do not express significant levels of OPN, into wild type and OPN-/- mice to investigate the role of microenvironment-derived OPN on glioblastoma progression. Results: Our data indicate that GAMs are the predominant source of OPN in both human and mouse glioblastoma and express only the secreted form of OPN. Loss of microenvironment-derived OPN enhanced tumor progression. Staining by Ki67 and terminal deoxynucleotidyl transferase deoxyuridine triphosphate nick end labeling showed no difference in overall cell proliferation but a decreased apoptosis rate in tumors in OPN-/- mice. CD31 staining showed a significantly decreased number of microvessels in tumors in OPN-/- mice, accompanied by reduced coverage of vessels with platelet derived growth factor receptor β+ pericytes. Flow cytometry analysis revealed a significant increase of CD11b+/CD45low microglia but not of CD11b+/CD45high macrophages/monocytes in tumors in OPN-/- mice. Sorted CD11b+ cells from wild type and OPN-/- naïve brains and tumors did not show a significant difference in the expression pattern of activation marker genes. Conclusion: Our results show that in tested human and mouse glioblastoma samples, OPN is predominantly expressed and secreted by GAMs and that, in contrast to OPN expression in the tumor cells per se, loss of stroma-derived OPN creates a glioblastoma-promoting microenvironment.
Background: Microglia and periphery-derived monocytes infiltrate human and mouseglioblastoma and their density is positively correlated with malignancy. Using microarray and RNA sequencing, we have previously shown that glioblastoma-associated microglia/monocytes (GAMs) express osteopontin/SPP1. Methods: We used quantitative reverse transcriptase PCR, immunofluorescence stainings, western blot, and flow cytometry to identify the various sources of osteopontin (OPN) expression in human and mouseglioblastoma. We implanted wild type GL261 glioblastoma cells, which do not express significant levels of OPN, into wild type and OPN-/- mice to investigate the role of microenvironment-derived OPN on glioblastoma progression. Results: Our data indicate that GAMs are the predominant source of OPN in both human and mouseglioblastoma and express only the secreted form of OPN. Loss of microenvironment-derived OPN enhanced tumor progression. Staining by Ki67 and terminal deoxynucleotidyl transferase deoxyuridine triphosphate nick end labeling showed no difference in overall cell proliferation but a decreased apoptosis rate in tumors in OPN-/- mice. CD31 staining showed a significantly decreased number of microvessels in tumors in OPN-/- mice, accompanied by reduced coverage of vessels with platelet derived growth factor receptor β+ pericytes. Flow cytometry analysis revealed a significant increase of CD11b+/CD45low microglia but not of CD11b+/CD45high macrophages/monocytes in tumors in OPN-/- mice. Sorted CD11b+ cells from wild type and OPN-/- naïve brains and tumors did not show a significant difference in the expression pattern of activation marker genes. Conclusion: Our results show that in tested human and mouseglioblastoma samples, OPN is predominantly expressed and secreted by GAMs and that, in contrast to OPN expression in the tumor cells per se, loss of stroma-derived OPN creates a glioblastoma-promoting microenvironment.
Authors: Nadia A Atai; Manju Bansal; Cheungh Lo; Joost Bosman; Wikky Tigchelaar; Klazien S Bosch; Ard Jonker; Philip C De Witt Hamer; Dirk Troost; Christopher A McCulloch; Vincent Everts; Cornelis J F Van Noorden; Jaro Sodek Journal: Immunology Date: 2010-08-17 Impact factor: 7.397
Authors: Virginie Lamour; Marie Le Mercier; Florence Lefranc; Martin Hagedorn; Sophie Javerzat; Andreas Bikfalvi; Robert Kiss; Vincent Castronovo; Akeila Bellahcène Journal: Int J Cancer Date: 2010-04-15 Impact factor: 7.396
Authors: Peiwen Chen; Di Zhao; Jun Li; Xin Liang; Jiexi Li; Andrew Chang; Verlene K Henry; Zhengdao Lan; Denise J Spring; Ganesh Rao; Y Alan Wang; Ronald A DePinho Journal: Cancer Cell Date: 2019-06-10 Impact factor: 31.743
Authors: Astrid De Boeck; Bo Young Ahn; Charlotte D'Mello; Xueqing Lun; Shyam V Menon; Mana M Alshehri; Frank Szulzewsky; Yaoqing Shen; Lubaba Khan; Ngoc Ha Dang; Elliott Reichardt; Kimberly-Ann Goring; Jennifer King; Cameron J Grisdale; Natalie Grinshtein; Dolores Hambardzumyan; Karlyne M Reilly; Michael D Blough; J Gregory Cairncross; V Wee Yong; Marco A Marra; Steven J M Jones; David R Kaplan; Kathy D McCoy; Eric C Holland; Pinaki Bose; Jennifer A Chan; Stephen M Robbins; Donna L Senger Journal: Nat Commun Date: 2020-10-05 Impact factor: 14.919